Signature Wealth Management Partners’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Signature Wealth Management Partners's LLY Position: Q1 2026 in Review
Signature Wealth Management Partners reduced its Eli Lilly (LLY) stake by 2.3% in Q1 2026, selling an estimated $24.3K and leaving 1,019 shares worth $937K. The position accounts for 0.47% of the portfolio, ranked #39.
Signature Wealth Management Partners first reported a position in LLY in Q2 2024 and has held it in 8 quarters since. The position peaked at $1.12M in Q4 2025. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Signature Wealth Management Partners held 1,019 shares of Eli Lilly worth $937K as of Q1 2026.
- Signature Wealth Management Partners sold 24 Eli Lilly shares in Q1 2026, an estimated $24.3K.
- Eli Lilly made up 0.47% of Signature Wealth Management Partners's portfolio in Q1 2026, its #39 holding.
- Signature Wealth Management Partners first reported a position in Eli Lilly in Q2 2024 and has held it in 8 quarters since.
- Signature Wealth Management Partners's Eli Lilly position peaked at $1.12M in Q4 2025.
- 4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Signature Wealth Management Partners's 13F filing for Q1 2026, filed 21 Apr 2026.